NCT00708812View on ClinicalTrials.gov

Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

December 31, 2009

Conditions

Advanced Non-small Cell Lung Cancer

Interventions

DRUG

Endostar(Recombinant Human Endostatin Injection)

Endostar 7.5mg/m2 on d8-d21 in each 21-day cycle

DRUG

paclitaxel-carboplatin

paclitaxel, 175mg/m2, iv, d1, q3w; carboplatin, AUC 5, iv, d1, q3w

Trial Locations (1)

200039

Shanghai Chest Hospital, Shanghai

All Listed Sponsors

lead

Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd

INDUSTRY

NCT00708812 - Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter